BIOL
Biolase, Inc.
BIOL
BIOL
Delisted
BIOL was delisted on the 18th of June, 2024.
35 hedge funds and large institutions have $27.4M invested in Biolase, Inc. in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Holders
35
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$41.4K | |
| 2 | +$27K | |
| 3 | +$15K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$15K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$14.9K |
Top Sellers
| 1 | -$44K | |
| 2 | -$32K | |
| 3 | -$19K | |
| 4 |
Morgan Stanley
New York
|
-$15.4K |
| 5 |
LPL Financial
San Diego,
California
|
-$15K |